Provant Health Revenue and Competitors

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • Provant Health's estimated annual revenue is currently $176.5M per year.(i)
  • Provant Health's estimated revenue per employee is $337,500

Employee Data

  • Provant Health has 523 Employees.(i)
  • Provant Health grew their employee count by -3% last year.

Provant Health's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.3M37N/AN/AN/A
Add Company

What Is Provant Health?

Provant is a health and wellness solutions company that partners with businesses to build cultures of health designed to improve the health, well-being, and productivity of employees while supporting employers with their healthcare affordability agenda. Provant's Life+ Program combines personalized “high touch” services with powerful social networking tools that link rewards to healthy behaviors and outcomes. The results of these programs: exceptional engagement, improved health, productive employees, and lower costs.

keywords:N/A

N/A

Total Funding

523

Number of Employees

$176.5M

Revenue (est)

-3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Provant Health News

2022-04-17 - Corporate Wellness Services Market Research Report By ...

... Revenue, Major Drivers, And Forecast To 2030: Wellness Corporate Solutions, ComPsych, Provant Health Solutions, Beacon Health Options,...

2022-04-17 - Corporate Wellness Programs Market Size, Outlook And ...

ComPsych, Virgin Pulse, Provant Health Solutions, Vitality Group, Interactive Health, Sodexo, FitLinxx. This comprehensive Corporate Wellness Programs...

2022-03-22 - United States Corporate Wellness Market Outlook & Forecast ...

... Featuring Key Vendors - Compsych, Wellness Corporate Solutions, Virgin Pulse, & Provant Health Solutions - ResearchAndMarkets.com.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$75M7632%N/A
#2
$353.6M77022%N/A
#3
$167.7M826N/AN/A
#4
$326.8M10616%N/A
#5
$75M11248%N/A